Skip to main content
discover hipra
Discover HIPRA

Building Immunity for a Healthier World

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.

A company that works with the latest technological advances to create innovative solutions that improve world health.

R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.

HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.

HIPRA About Us

Excellence, optimism and nonconformism

Values are the company’s DNA and the impulse to achieve common goals. They unite a great team, multicultural and with different talents.


EXCELLENCE as our hallmark

OPTIMISM as our way of being


HIPRA in figures
2000 employees around the world
40 HIPRA operating and distribution subsidiaries
Operating & distribution subsidiaries
100 countries where HIPRA is present
Countries where is present
6 HIPRA production plants
Production plants
3 HIPRA R&D centers
R&D centers
11 diagnostic centers
Diagnostic centers
Non-financial statement

In order to comply with Law 11/2018 of December 28th, HIPRA hereby publishes the Non-Financial Information Statement included in our yearly Consolidated Management Report:

HIPRA building
Report 2023
Report 2022
Report 2021
Report 2020
Report 2019